Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

Share Embed


Descripción

Vaccine development in human Plasmodium falciparum malaria has been hampered by the exceptionally high levels of CD8(+) T cells required for efficacy. Use of potently immunogenic human adenoviruses as vaccine vectors could overcome this problem, but these are limited by preexisting immunity to human adenoviruses.
Lihat lebih banyak...

Comentarios

Copyright © 2017 DATOSPDF Inc.